Also known as: STADA
STADA Arzneimittel is a German pharmaceutical company focused on consumer healthcare, generics, and specialty pharma products. Founded in 1895 and headquartered in Bad Vilbel, it markets products in around 120 countries. The company has historical listing references under FWB:SAZ and has been owned by private equity since 2017.
Aurobindo Pharma's subsidiaries secured Health Canada approval for bevacizumab biosimilar Bevqolva, an EU distribution deal with STADA for two EMA-approved biosimilars, and US FDA approval for ADQUEY ointment for atopic dermatitis.
The European Commission has approved Gotenfia (golimumab), a biosimilar to Simponi developed by Bio-Thera and marketed by STADA, for chronic inflammatory autoimmune diseases across the EU and EEA.
The European Commission has granted marketing authorization for Gotenfia, a golimumab biosimilar to Simponi, developed by Bio-Thera and to be commercialized by STADA across the EU, EEA, UK, Switzerland and selected other countries.
